| 000 | 01593 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513132155.0 | ||
| 264 | 0 | _c19971223 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0165-5728 | ||
| 024 | 7 |
_a10.1016/s0165-5728(97)00106-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerez, L | |
| 245 | 0 | 0 |
_aConditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cNov 1997 |
||
| 300 |
_a101-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAvoidance Learning _xphysiology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aConditioning, Classical _xphysiology |
| 650 | 0 | 4 | _aElectroshock |
| 650 | 0 | 4 |
_aImmune System _xdrug effects |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNaloxone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aNaltrexone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Lew |
| 650 | 0 | 4 |
_aReceptors, Opioid, delta _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Opioid, kappa _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Opioid, mu _xphysiology |
| 650 | 0 | 4 |
_aSpleen _xcytology |
| 700 | 1 | _aLysle, D T | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 79 _gno. 2 _gp. 101-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(97)00106-9 _zAvailable from publisher's website |
| 999 |
_c9364473 _d9364473 |
||